Evofem Biosciences, Inc. (EVFM)
- Previous Close
0.0084 - Open
0.0084 - Bid 0.0084 x --
- Ask 0.0087 x --
- Day's Range
0.0084 - 0.0084 - 52 Week Range
0.0060 - 0.0200 - Volume
45,399 - Avg. Volume
495,408 - Market Cap (intraday)
906,848 - Beta (5Y Monthly) -1.00
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1200 - Earnings Date Aug 12, 2025 - Aug 18, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a vaginal gel for the prevention of pregnancy; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
www.evofem.comRecent News: EVFM
View MorePerformance Overview: EVFM
Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EVFM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EVFM
View MoreValuation Measures
Market Cap
952.19k
Enterprise Value
46.92M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.03
Price/Book (mrq)
--
Enterprise Value/Revenue
2.42
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-45.76%
Return on Assets (ttm)
-27.94%
Return on Equity (ttm)
--
Revenue (ttm)
19.36M
Net Income Avi to Common (ttm)
-8.96M
Diluted EPS (ttm)
-0.1200
Balance Sheet and Cash Flow
Total Cash (mrq)
127k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-3.88M